Matthew Gregory Cohen insider trades
Open-market stock purchases and sales by Matthew Gregory Cohen, Director at Arrowhead Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 15, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 15, 2026 | ARWR Arrowhead Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- ARWR Arrowhead Pharmaceuticals, Inc: other filings, last Jun 15, 2026
Get free alerts when Matthew Gregory Cohen files a new trade →